Cite
HARVARD Citation
Vaca, S. et al. (2018). Commentary: Treatment Considerations for Patients With Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Brain Metastases in the Era of Tyrosine Kinase Inhibitors. Neurosurgery. 82 (1), pp. E6-E14. [Online].